Li Jing, Li Gang, Zhu Yajun, Lei Xingwei, Chen Guihu, Zhang Jiachun, Sun Xiaochuan
Department of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Front Neurol. 2023 Feb 28;14:1114176. doi: 10.3389/fneur.2023.1114176. eCollection 2023.
Current studies indicate a contradictory relationship between decreased mortality risks of spontaneous intracerebral hemorrhage (sICH) and elevated low-density lipoprotein cholesterol (LDL-C) levels. Thus, this meta-analysis was designed to examine the involvement of high LDL-C levels in a lower mortality risk of sICH patients.
PubMed, Cochrane, and Embase databases were searched up to the date of August 3rd, 2022. Pooled odds ratio (OR) with a 95% confidence interval (CI) was estimated for the higher vs. lower serum LDL-C level groups. Subgroup and sensitivity analyses were also carried out. Egger's test was applied to detect any potential publication bias.
Of 629 citations reviewed, 8 eligible cohort studies involving 83,013 patients were enrolled in this meta-analysis. Compared with lower serum LDL-C levels containing patients, higher serum LDL-C patients exhibited significantly decreased risks of 3-month mortality (OR: 0.51; 95%CI: 0.33-0.78; I = 47.8%); however, the LDL-C level change wasn't significantly associated with in-hospital mortality risks (OR: 0.92; 95%CI: 0.63-1.33; I = 91.4%) among sICH subjects. All studies included were classified as high-quality investigations.
This meta-analysis suggests a higher LDL-C level may decrease the mortality risk in sICH patients. LDL-C level increase is inversely associated with the 3-month mortality risks in these patients but not significantly correlated with the in-hospital mortality risks. Further well-designed prospective studies with extended follow-up periods are needed to confirm these findings and explore underlying cross-talks.
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022318318, identifier: PROSPERO 2022 CRD42022318318.
目前的研究表明,自发性脑出血(sICH)患者死亡率降低与低密度脂蛋白胆固醇(LDL-C)水平升高之间存在矛盾关系。因此,本荟萃分析旨在研究高LDL-C水平与sICH患者较低死亡率风险之间的关系。
检索截至2022年8月3日的PubMed、Cochrane和Embase数据库。对血清LDL-C水平较高组与较低组进行合并比值比(OR)及95%置信区间(CI)的估计。同时进行亚组分析和敏感性分析。采用Egger检验检测潜在的发表偏倚。
在检索的629篇文献中,本荟萃分析纳入了8项符合条件的队列研究,共83,013例患者。与血清LDL-C水平较低的患者相比,血清LDL-C水平较高的患者3个月死亡率风险显著降低(OR:0.51;95%CI:0.33-0.78;I² = 47.8%);然而,在sICH患者中,LDL-C水平变化与住院死亡率风险无显著相关性(OR:0.92;95%CI:0.63-1.33;I² = 91.4%)。所有纳入研究均被归类为高质量研究。
本荟萃分析表明,较高的LDL-C水平可能降低sICH患者的死亡风险。LDL-C水平升高与这些患者3个月死亡率风险呈负相关,但与住院死亡率风险无显著相关性。需要进一步设计良好的前瞻性研究,并延长随访期,以证实这些发现并探索潜在的相互作用机制。
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022318318,标识符:PROSPERO 2022 CRD42022318318